> NZ April Prelim ANZ Business Confidence : -8.4 v. -4.1 prev.
> EU February German Factory Orders : 1.2% v. 1.3% exp.
> US Unemployment Claims : 744K v. 682K exp.
Overnight Headlines (BBG)
> The local vaccine rollout continues to struggle, while the blood clotting issue from the AstraZeneca vaccine has caused the government to recommend no one under the age of 50 receive the vaccine, a huge part of the population
> US Fed Chair Powell continues to downplay inflation risks, commenting that the Fed would take action if there was sustained inflationary pressures
What you need to know
A very uneventful Asian session, with a light data docket most markets traded sideways for the majority of the day. The GBPUSD lead the moves higher during late Asia, with the Aussie following the move and slowly trickling higher as the European volume started to come into play. Late in the evening, the local vaccine rollout stalled yet again as the government changed their recommendations on the vaccine with those under the age of 50 likely to be given another choice. The problem is, Australia is going to struggle to retain the amount of doses required to vaccinate the population in the near term, so expect borders to stay closed for the remainder of the year. The NZ/AU travel bubble is already seeing some jitters before it starts with a border staff member testing positive in NZ, with those expecting to book a trip across the Tasman likely to do so with a high risk.
In Europe, inflation seems to be picking up across the region as the cost of consumer goods rose in what is likely to be the norm in coming months. The ECB’s meeting minutes showed that there was some back and forth between members on the pace of the PEPP program, while the biggest concern remains the rising COVID19 cases and the lack of vaccinations across the member countries. US markets relatively subdued, with investors awaiting commentary from the Chair of the Fed. Fed Chairman Powell commented that he didn’t believe inflation is going to be a real risk, with yields falling sharply across the curve and seeing US equity markets post further gains. The Dollar is down 0.4% as the correction continues, with 92.00 fast approaching on the DXY. With risk appetite turning positive, both the AUD and NZD are up on the session with the Kiwi outperforming. Lots of green in commodity markets, with Gold the biggest winner up over 1%, while WTI crude is up 0.6%. US job numbers missed the mark, with unemployment claims gaining in the week. The next headlines from the US will all be about Biden’s plan to rebuild America, with the help from a sharp increase in taxes.
The Day Ahead
> AU March AIG Services Index : 55.8 prev.
> AU RBA Financial Stability Review
> CN March CPI & PPI : 0.3% & 3.6% exp.
> EU February German Industrial Production & Trade Balance : 1.6% & 23.4Bio exp.
> CA March Employment Change & Unemployment Rate : 101.5K & 8.0% exp.
> US March Core PPI & H/line PPI : 0.2% & 0.5% exp.
The RBA’s financial stability review will be the day’s highlight followed by both consumer and producer inflation numbers out of China. Keeping a close eye on producer inflation numbers, with a continued move higher in producer prices likely to ignite yet another bout of inflation fears, although that seems to be a problem of last month. No reason to really break the range yet again, eyes looking ahead to next week’s job figures although we will need to wait until May to see how the removal of Jobkeeper has impacted the labour market.
Range for the day : 0.7610 – 0.7670
Range bound yet again, and its been a tight range for the week with the sparse data docket a factor. 50/100DMA range remains the key, with a break of 0.7600 needed to see a potential test of the fresh low of 0.7532. Not expecting that today, while upside remains capped by the elusive 0.7660 level, which has been a tough nut to crack.
“Cambridge Global Payments” is a trade name, which in this document refers specifically to one or more of these legal entities: Cambridge Mercantile Corp., Cambridge Mercantile Corp. (U.S.A.), Cambridge Mercantile Corp. (Nevada), Cambridge Mercantile (Australia) Pty. Ltd.
Cambridge Global Payments (“Cambridge”) provides this document as general market information subject to: Cambridge’s copyright, and all contract terms in place, if any, between you and the Cambridge entity you have contracted with. This document is based on sources Cambridge considers reliable, but without independent verification. Cambridge makes no guarantee of its accuracy or completeness. Cambridge is not responsible for any errors in or related to the document, or for damages arising out of any person’s reliance upon this information. All charts or graphs are from publicly available sources or proprietary data. The information in this document is subject to sudden change without notice.
Cambridge may sell to you and/or buy from you foreign exchange instruments (including spot and/or derivative transactions; both kinds are here called “FXI”s) covered by Cambridge on a principal basis.
This document is NOT: 1) Advice of any kind, or 2) Approved or reviewed by any regulatory authority, or 3) An offer to sell or a solicitation of an offer to buy any FXIs, or to participate in any trading strategy.
Before acting on this document, you must consider the appropriateness of the information, based on your objectives, needs and finances. For advice, you must contact someone independent of Cambridge.
Certain FXIs mentioned in this document may be ineligible for sale in some locations, and/or unsuitable for you. Contact your Cambridge representative for further information regarding product availability/suitability before you enter into any FXI contract.
FXIs are volatile and may cause losses. Past performance of a FXI product cannot be relied on to determine future performance.
This document is intended only for persons in Canada, the US, and Australia. This document is not intended for persons in the UK or elsewhere in the EEA. In Australia, this publication has been distributed by Cambridge Mercantile (Australia) Pty. Ltd. (ABN 85 126 642 448, AFSL 351278); for the general information of its customers (as defined in the Corporations Act 2001). This entity makes no representations that the products or services mentioned in this document are available to persons in Australia or are necessarily suitable for any particular person or appropriate in accordance with local law.
Fees may be earned by Cambridge (and its agents) in respect of any business transacted with Cambridge.
The document is intended to be distributed in its entirety. Unless governing law permits otherwise, you must contact the applicable Cambridge if you wish to use Cambridge services to enter a transaction involving any instrument mentioned in this document.
© Copyright 2018, Cambridge Mercantile Corp., ALL RIGHTS RESERVED. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, on any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of Cambridge Mercantile Corp. See www.cambridgefx.com for contact details.